Selecta Biosciences Inc. (SELB)
NASDAQ: SELB
· Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM
Selecta Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.1M | 21.18M | 387K | 6.55M | 5.25M | 5.94M | 16.8M | 20.71M | 39.27M | 34M | 29.94M | 24.43M | 19.66M | 11.05M |
Cost of Revenue | n/a | 2.51M | n/a | n/a | 17.78M | 18.62M | 18.97M | 16.54M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 18.67M | n/a | 6.55M | -12.53M | -12.69M | -2.17M | 4.17M | 39.27M | 34M | 29.94M | 24.43M | 19.66M | 11.05M |
Operating Income | n/a | 50.08M | n/a | -13.06M | -18.64M | -18.38M | -8.5M | -1.6M | 13.86M | 10.77M | 4.08M | -1.97M | 452K | -7.16M |
Interest Income | 2.02M | 6.22M | n/a | n/a | 642K | 523K | 334K | 92K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -17.71M | -35.09M | -24.18M | -9M | -11.39M | -21.66M | 5.61M | -8.21M | 8.6M | 28.78M | 12.38M | -2.07M | 4.57M | -24.6M |
Net Income | -17.71M | -31.28M | -24.18M | -9M | -11.39M | -25.75M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M | 4.57M | -24.6M |
Selling & General & Admin | 8.31M | 11.71M | 6.56M | 6.61M | 6.11M | 5.7M | 6.32M | 5.77M | 6.23M | 5.54M | 5.54M | 5.45M | 4.75M | 5.2M |
Research & Development | 14.67M | 4.3M | 11.4M | 13M | 17.78M | 18.62M | 18.97M | 16.54M | 19.18M | 17.69M | 20.32M | 20.95M | 14.46M | 13M |
Other Expenses | n/a | n/a | n/a | n/a | 245K | 255K | 175K | 1K | n/a | 154K | n/a | 9K | 6K | n/a |
Operating Expenses | 22.99M | 16.02M | 17.96M | 19.62M | 23.89M | 24.32M | 25.29M | 22.31M | 25.41M | 23.23M | 25.86M | 26.4M | 19.21M | 18.21M |
Interest Expense | n/a | -2.83M | n/a | 1.27M | 752K | 808K | 807K | 802K | 715K | 707K | 711K | 711K | 711K | 711K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 18.52M | n/a | 19.62M | 23.89M | 24.32M | 25.29M | 22.31M | 25.41M | 23.23M | 25.86M | 26.4M | 19.21M | 18.21M |
Income Tax Expense | n/a | -5.18M | n/a | n/a | n/a | 4.09M | -288K | -321K | n/a | n/a | 138K | 15.83M | n/a | n/a |
Shares Outstanding (Basic) | 155.11M | 155.11M | 155.11M | 154.8M | 153.44M | 153.35M | 145.87M | 152.85M | 148.51M | 124.23M | 117.79M | 111.84M | 113.52M | 110.74M |
Shares Outstanding (Diluted) | 155.11M | 155.11M | 155.11M | 154.8M | 153.44M | 153.35M | 145.87M | 152.85M | 148.51M | 127.57M | 124.06M | 115.17M | 121.18M | 110.74M |
EPS (Basic) | -0.11 | -0.2 | -0.16 | -0.06 | -0.07 | -0.17 | 0.03 | -0.05 | 0.06 | 0.23 | 0.10 | -0.16 | 0.04 | -0.22 |
EPS (Diluted) | -0.11 | -0.2 | -0.16 | -0.06 | -0.07 | -0.17 | 0.03 | -0.05 | 0.06 | 0.23 | 0.10 | -0.16 | 0.04 | -0.22 |
EBITDA | n/a | -40.13M | n/a | -13.06M | -18.22M | -17.92M | -8.08M | -1.25M | 13.86M | 11.28M | 4.08M | -1.62M | 763K | -6.95M |
EBIT | n/a | 41.77M | n/a | -10.28M | -10.63M | -20.86M | 6.41M | -7.41M | 9.32M | 29.48M | 13.09M | -1.35M | 5.28M | -23.89M |
Depreciation & Amortization | n/a | -826K | n/a | 189K | 176K | 461K | 416K | 351K | 345K | 505K | 401K | 339K | 305K | 207K |